Status and clinical response of fertility preservation in young patients with breast cancer
10.3760/cma.j.cn112139-20201013-00750
- VernacularTitle:年轻乳腺癌患者生育力保存现状与临床应对策略
- Author:
Yuyun CHEN
1
;
Kejin WU
Author Information
1. 复旦大学附属妇产科医院乳腺科，上海 200011
- Keywords:
Breast neoplasms;
Fertility;
Yound adults
- From:
Chinese Journal of Surgery
2021;59(2):104-108
- CountryChina
- Language:Chinese
-
Abstract:
Cancer treatments may improve the long-term survival rate of young patients with breast cancer, but also lead to a decrease in fertility. With the younger incidence of breast cancer in China, the fertility needs of this group have received more attention, and fertility preservation technology suitable for cancer patients is developing continuously. However, there are still many problems in the implementation of fertility preservation for young breast cancer patients in China. Patients and breast surgeons have insufficient understanding and conservative attitudes towards fertility preservation technology. And there is a lack of reproductive experts in the treatment process. What′s more, the long-term follow-up and information management of patients undergoing fertility preservation are defective. In response to the above, this paper discusses how to deal with patients with potential reproductive needs in clinical practice from the perspective of breast surgeons. The first is to improve their own understanding of fertility preservation, such as the progress of relevant technologies and applicable population, when to intervene, when and how to get pregnant after cancer treatment. Secondly, education for patients must be strengthened, which should include not only fertility preservation, but also scientific contraceptive methods during cancer treatment and treatment measures for unexpected pregnancy. Finally, hospitals and relevant units should standardize the multidisciplinary team of breast cancer, and strengthen the comprehensive management of young breast cancer patients, thus to provide young breast cancer patients with more scientific cancer treatment programs and more reproductive opportunities.
